Trials / Completed
CompletedNCT02791750
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
5 Years Follow-up in the Lorraine Institute of Oncology With Adjuvant Therapy for Women With Breast Invasive Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Institut de Cancérologie de Lorraine · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Non-persistence to adjuvant hormonal therapy for breast cancer at 5 years decrease its efficacy. The objective of this study is to know the women experience (persistence, treatment changes, quality of life) and its determinants, in a french population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnary of quality of life |
Timeline
- Start date
- 2016-06-03
- Primary completion
- 2017-06-03
- Completion
- 2017-06-03
- First posted
- 2016-06-07
- Last updated
- 2018-08-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02791750. Inclusion in this directory is not an endorsement.